ART-TG is an innovation and development laboratory for cell and gene therapy, established by Inserm. Its mission is to accelerate the transfer of promising research discoveries towards clinical stages, which ultimately will ensure that the best gene therapies will be available for patients.

​

Anne Galy, founder of ART-TG (view her bio)

​

ART-TG supports the development of preclinical projects and de-risks production processes through its MAGENTA integrator capacity.